WebMar 27, 2024 · By Chris Wack. BrainStorm Cell Therapeutics Inc. shares were up 13%, to $1.75, after the company said that the U.S. Food and Drug Administration will hold an Advisory Committee Meeting to discuss ... WebApr 6, 2024 · A high-level overview of Brainstorm Cell Therapeutics Inc. (BCLI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Does Brainstorm Cell Therapeutics Inc (BCLI) Have What it Takes to …
Web2 days ago · Get a real-time Brainstorm Cell Therapeutics Inc. (BCLI) stock price quote with breaking news, financials, statistics, charts and more. ... the average rating for BCLI stock is "Buy." The 12-month stock price forecast is $15.3, which is an increase of 434.97% from the latest price. Price Target. $15.3 (434.97% upside) Analyst Consensus: Buy ... WebAug 5, 2024 · The market (NASDAQ average) beta is 1, while Brainstorm Cell Therapeutics's is -0.4472. This would suggest that Brainstorm Cell Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Brainstorm Cell Therapeutics has bucked the trend. dr. lee soo-chan directory
Will Cidara Therapeutics Inc (CDTX) Stay at the Top of the …
WebApr 12, 2024 · Codiak BioSciences presently has a consensus price target of $4.20, indicating a potential upside of 22,480.65%. Brainstorm Cell Therapeutics has a consensus price target of $10.00, indicating a ... WebMar 27, 2024 · Conference call and webcast at 8:00 a.m. ET. NEW YORK, March 27, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting … WebDec 14, 2024 · NEW YORK, Dec. 14, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today the initiation of a NurOwn® (MSC-NTF cells) Expanded Access Program (EAP) for patients with amyotrophic lateral … dr. lee south bend indiana